Letybo® Botulinum Toxin Type A Expiry 28.02.2027

Letybo® Botulinum Toxin Type A 

Letybo® contains the active substance botulinum toxin type A. It works by blocking nerve impulses to the muscles in which it has been injected. It prevents muscles from contracting, leading to a temporary paralysis.
Letybo® is used in adults less than 75 years of age to temporarily improve moderate to severe vertical lines between the eyebrows, when their presence has a significant psychological impact on them.

The recommended dose is 20 units divided into five injections of 0.1 mL (4 units). Each injection is given into the muscles above or between the eyebrows. Letybo® is for intramuscular use (IM use). After the solution is reconstituted, the vial must be used only for one session per patient. Any unused solution must be discarded, as explained after section 6 in the information for healthcare professionals. It is recommended to leave a minimum of 3 months between two treatments with Letybo®.

The active substance is botulinum toxin type A. One vial contains 50 units botulinum toxin type A produced by Clostridium botulinum. After reconstitution each 0.1 mL of the solution contains 4 units. The other excipients are human albumin and sodium chloride.